FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200220854> ?p ?o ?g. }

• W4200220854 endingPage "e054681" @default.
• W4200220854 startingPage "e054681" @default.
• W4200220854 abstract "Postoperative pain remains incompletely controlled for decades. Recently, multimodal analgesia is emerging as a potential approach in the management of postoperative pain. Therein, S(+)-ketamine is appealing as an adjuvant drug in multimodal analgesia due to its unique pharmacological advantages. This pragmatic clinical trial (SAFE-SK-A trial) is designed to investigate the analgesic effect and safety of S(+)-ketamine for acute postoperative pain in adults and explore the optimal strategy of perioperative intravenous S(+)-ketamine in a real-world setting.This multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A study) is planned to conduct in 80 centres from China and recruit a total of 12 000 adult participants undergoing a surgical procedure under general anaesthesia. Patient recruitment started in June 2021 and will end in June 2022. Participants will be randomised in a ratio of 2:1 to either receive perioperative intravenous S(+)-ketamine plus conventional anaesthesia or conventional anaesthesia only. Given the pragmatic nature of the study, no specific restriction as to the administration dosage, route, time, synergistic regimen or basic analgesics. Primary endpoints are the area under the broken line of Numerical Rating Scale (NRS) scores for pain intensity and the total opioid consumption within 48 hours postoperative. Secondary endpoints are postoperative NRS scores, the anaesthesia recovery time, time of first rescue analgesia, the incidence of rescue analgesia, the incidence of postoperative delirium, patient questionnaire for effect, changes from baseline in cognitive function and anxiety and depression, as well as the adverse events and pharmacoeconomic outcomes. The general linear model will be used for the primary endpoint, and appropriate methods will be used for the secondary endpoints.This trial has been approved by the local Institutional Review Board (S2021-026-02) and conducted following the Declaration of Helsinki. Results of this trial will be publicly disclosed and published in scientific journals.NCT04837170; Pre-results." @default.
• W4200220854 created "2021-12-31" @default.
• W4200220854 creator A5012491543 @default.
• W4200220854 creator A5014236757 @default.
• W4200220854 creator A5019560977 @default.
• W4200220854 creator A5024834490 @default.
• W4200220854 creator A5030863883 @default.
• W4200220854 creator A5037233428 @default.
• W4200220854 creator A5042458010 @default.
• W4200220854 creator A5051396544 @default.
• W4200220854 creator A5055466049 @default.
• W4200220854 creator A5058260994 @default.
• W4200220854 creator A5065933735 @default.
• W4200220854 creator A5066124548 @default.
• W4200220854 creator A5066470242 @default.
• W4200220854 creator A5078210046 @default.
• W4200220854 creator A5082213642 @default.
• W4200220854 creator A5082502067 @default.
• W4200220854 date "2021-12-01" @default.
• W4200220854 modified "2023-09-26" @default.
• W4200220854 title "Perioperative intravenous S(+)-ketamine for acute postoperative pain in adults: study protocol for a multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A trial)" @default.
• W4200220854 cites W1995653940 @default.
• W4200220854 cites W2072369333 @default.
• W4200220854 cites W2113578435 @default.
• W4200220854 cites W2125651930 @default.
• W4200220854 cites W2137395801 @default.
• W4200220854 cites W2322548405 @default.
• W4200220854 cites W2398894315 @default.
• W4200220854 cites W2502215687 @default.
• W4200220854 cites W2517712512 @default.
• W4200220854 cites W2559490396 @default.
• W4200220854 cites W2582210188 @default.
• W4200220854 cites W2591849971 @default.
• W4200220854 cites W2760543293 @default.
• W4200220854 cites W2796224977 @default.
• W4200220854 cites W2971779310 @default.
• W4200220854 cites W2976551206 @default.
• W4200220854 cites W2981432831 @default.
• W4200220854 cites W2992709942 @default.
• W4200220854 cites W2997218414 @default.
• W4200220854 cites W3000460077 @default.
• W4200220854 cites W3089720030 @default.
• W4200220854 cites W4249049705 @default.
• W4200220854 cites W53247198 @default.
• W4200220854 doi "https://doi.org/10.1136/bmjopen-2021-054681" @default.
• W4200220854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34916327" @default.
• W4200220854 hasPublicationYear "2021" @default.
• W4200220854 type Work @default.
• W4200220854 citedByCount "3" @default.
• W4200220854 countsByYear W42002208542022 @default.
• W4200220854 countsByYear W42002208542023 @default.
• W4200220854 crossrefType "journal-article" @default.
• W4200220854 hasAuthorship W4200220854A5012491543 @default.
• W4200220854 hasAuthorship W4200220854A5014236757 @default.
• W4200220854 hasAuthorship W4200220854A5019560977 @default.
• W4200220854 hasAuthorship W4200220854A5024834490 @default.
• W4200220854 hasAuthorship W4200220854A5030863883 @default.
• W4200220854 hasAuthorship W4200220854A5037233428 @default.
• W4200220854 hasAuthorship W4200220854A5042458010 @default.
• W4200220854 hasAuthorship W4200220854A5051396544 @default.
• W4200220854 hasAuthorship W4200220854A5055466049 @default.
• W4200220854 hasAuthorship W4200220854A5058260994 @default.
• W4200220854 hasAuthorship W4200220854A5065933735 @default.
• W4200220854 hasAuthorship W4200220854A5066124548 @default.
• W4200220854 hasAuthorship W4200220854A5066470242 @default.
• W4200220854 hasAuthorship W4200220854A5078210046 @default.
• W4200220854 hasAuthorship W4200220854A5082213642 @default.
• W4200220854 hasAuthorship W4200220854A5082502067 @default.
• W4200220854 hasBestOaLocation W42002208541 @default.
• W4200220854 hasConcept C126322002 @default.
• W4200220854 hasConcept C141071460 @default.
• W4200220854 hasConcept C142724271 @default.
• W4200220854 hasConcept C168563851 @default.
• W4200220854 hasConcept C177713679 @default.
• W4200220854 hasConcept C197934379 @default.
• W4200220854 hasConcept C2776983577 @default.
• W4200220854 hasConcept C2779753318 @default.
• W4200220854 hasConcept C2780651394 @default.
• W4200220854 hasConcept C2780795376 @default.
• W4200220854 hasConcept C2780820201 @default.
• W4200220854 hasConcept C2781413609 @default.
• W4200220854 hasConcept C31174226 @default.
• W4200220854 hasConcept C42219234 @default.
• W4200220854 hasConcept C535046627 @default.
• W4200220854 hasConcept C71924100 @default.
• W4200220854 hasConceptScore W4200220854C126322002 @default.
• W4200220854 hasConceptScore W4200220854C141071460 @default.
• W4200220854 hasConceptScore W4200220854C142724271 @default.
• W4200220854 hasConceptScore W4200220854C168563851 @default.
• W4200220854 hasConceptScore W4200220854C177713679 @default.
• W4200220854 hasConceptScore W4200220854C197934379 @default.
• W4200220854 hasConceptScore W4200220854C2776983577 @default.
• W4200220854 hasConceptScore W4200220854C2779753318 @default.
• W4200220854 hasConceptScore W4200220854C2780651394 @default.
• W4200220854 hasConceptScore W4200220854C2780795376 @default.
• W4200220854 hasConceptScore W4200220854C2780820201 @default.
• W4200220854 hasConceptScore W4200220854C2781413609 @default.
• W4200220854 hasConceptScore W4200220854C31174226 @default.

• next